Comparison of plasma methylated SEPT9 screening marker in both left- and right-sided colon cancer to GFOBT and CEA results
Katalin Tóth(Semmelweis University), Zsolt Tulassay(Semmelweis University), Henriette Golcher(Friedrich-Alexander-Universität Erlangen-Nürnberg), Barbara Kinga Barták(Semmelweis University), Alexandra Kalmár(Semmelweis University), Zsófia Brigitta Nagy(Semmelweis University), Katalin Leiszter(Semmelweis University), Vera Schellerer, Ferenc Sípos(Semmelweis University), A Schöller(Semmelweis University), Barnabás Wichmann(Semmelweis University), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Béla Molnár(Semmelweis University), VÁ Patai(Semmelweis University), Gábor Valcz(Hungarian Academy of Sciences)
Cited by 0
Related Papers
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
|Molecular Cancer Research|2010|227